I just toss my hats anywhere (can always wash them). You're right in your thinking, but inasmuch as trials and efficacy are needed before company can think of filing for NDA, it's a ways off. Who knows? The DIPG data could be mind-blowing. The extension of Josie Dun's life was certainly impressive when she was started on Pax after the end of her expected lifespan for that disease. Fast-tracking is a real possibility. I don't think an NDA filing will happen in the next couple months, though. I'd love to be wrong.
KZA Price at posting:
82.0¢ Sentiment: Buy Disclosure: Held
